CareDx

Traded on the St. Petersburg Stock Exchange
CareDx, Inc., is a precision medicine solutions company focused on the discovery, development and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers.
CareDx stock price chart
vol.
change
P/E adj.
Net profit (adj.)
P/B
Book value
P/FCF
FCF
Yield
Growth potential

CareDx balance sheet

Report period2018 2019 2020 2021 2022 Q3 23
End date of the reporting period
Capitalization, $
Capitalization, $
Enterprise Value
Book Value
Shareholders Book Value
Current liabilities
Noncurrent liabilities
Total liabilities
Debt
Cash and cash equivalents
Net debt
Assets
Total ordinary shares
Ordinary share price

CareDx cash flows

Report period2018 2019 2020 2021 2022 Q3 23 TTM
End date of the reporting period
Sales
Gross profit
Operation Income
Earnings
Shareholders earnings
Adjusted Earnings
EBITDA
Adjusted EBITDA
Operation Cashflow
Capital expenditure
Free Cash Flow
EPS
Adjusted EPS

CareDx multipliers

Report period2018 2019 2020 2021 2022 Q3 23 TTM
P/E
P/E adj.
E/P
E adj./P
P/B
P/S
P/FCF
L/A
Debt-To-Equity
Net Debt/EBITDA
Net Debt/EBITDA adj.
EV/EBITDA
EV/EBITDA adj.

CareDx profitability

Report period2018 2019 2020 2021 2022 Q3 23 TTM
ROA
ROE
ROS
Gross margin
EBITDA Margin
Operating margin
CareDx assets
CareDx cash flows

CareDx shares

TickerNameTypeNominal valueISINPrice
CDNA:USCareDx, Inc.Common share-US14167L1035$21.17
CareDx news
06.05.2022
CareDx's GAAP loss for 3 months of 2022 was $19.648 million, up 28.6 times from $0.687 million in the prior year. Revenue increased 17.8% to $79.416 million from $67.4 million a year earlier.
Source: {source} pictogram investors.caredxinc.com
Pictogram next
25.02.2022
CareDx's GAAP loss for 2021 was $30.662 million, up 63.8% from $18.714 million in the prior year. Revenue increased 54.2% to $296.397 million from $192.194 million a year earlier.
Source: {source} pictogram investors.caredxinc.com
Pictogram next
05.01.2022
CareDx has acquired The Transplant Pharmacy, a chain of pharmacies that provides personalized services to transplant center patients located throughout the United States. Terms of the deal were not disclosed.
Source: {source} pictogram investors.caredxinc.com
Pictogram next
28.10.2021
CareDx posted a GAAP loss of $14.511 million for 9M 2021, down 4.5% from $15.199 million in the previous year. Revenues increased 62.6% to $217.177 million compared to $133.55 million a year earlier.
Source: {source} pictogram investors.caredxinc.com
Pictogram next
All CareDx news
General information
Company nameCareDx
Tags#katie wood's choice
SectorHealth Care / Health Care Equipment & Services / Health Care Equipment & Supplies / Health Care Supplies
Business address3260 BAYSHORE BOULEVARD BRISBANE CA 94005 415-287-2300
Mailing address3260 BAYSHORE BOULEVARD BRISBANE CA 94005
Websiteinvestors.caredxinc.com
Information disclosurewww.sec.gov